Le Lézard
Classified in: Health, Science and technology
Subject: CORRECTIONS

CORRECTION FROM SOURCE: Calyx Provides Corporate Update


VANCOUVER, BRITISH COLUMBIA--(Marketwired - Jan. 30, 2017) -

This document corrects and replaces the press release that was sent today at 8:00 am ET. The embedded URL was changed.

Calyx Bio-Ventures Inc. (TSX VENTURE:CYX) ("Calyx" or the "Company") is pleased to provide to an update on its ongoing business operations and the development of its industry leading technology platform for mass communications and collaboration.

Highlights of the Company's recent developments include:

In addition, the last few months has seen the external environment shifting dramatically. Eight states representing 22% of the United States population voted to regulate the production and sale of cannabis, potentially opening up new markets for LEAFHub of an estimated 10 million regular cannabis consumers now residing in states with medical or recreational cannabis laws.

"We are very pleased with the recent achievements and growth trajectory that Calyx is currently experiencing," stated Roger Forde, President and Chief Executive Officer of Calyx. "We are in the midst of an exciting stage in this rapidly expanding industry, with new regulations and studies making cannabis more widely accepted than ever before. Calyx is confident that it is ideally positioned to leverage the numerous opportunities within the expanding legal cannabis market. We are committed to executing on our strategy, adding users and features to our best-in-class technology platform to drive adoption and take a leading position in the sector."

For additional information, readers are encouraged to review the Company's letter to its shareholders, published concurrently with this news release, and available through the following link:

http://calyxbio.com/wp-content/uploads/2017/01/Calyx-Chairmans-Letter-v.2-2017-01-30.pdf

About Calyx

In addition to Calyx's portfolio of proprietary intellectual property with applications in crop enhancement, its wholly-owned subsidiary, Cannigistics Agri-Solutions Corp., is a software development company that has created a software platform tailored to advanced indoor agriculture. The Cannigistics software platform is designed to enhance the efficiency and effectiveness of indoor agricultural operations, and positions Cannigistics to be the industry leader in agri-software solutions by providing businesses with advanced controls over all aspects of their operations. Recent upgrades have also generated interest in the software platform from outside the agriculture industry which could potentially provide additional areas of growth for the Company.

For further information about Calyx, please visit www.calyxbio.com.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This document contains certain forward-looking statements concerning Calyx, as well as other expectations, plans, goals, objectives, information or statements about future events, conditions, or performance that may constitute "forward-looking statements" or "forward-looking information" under applicable securities legislation. Such statements or information involve substantial known and unknown risks and uncertainties, certain of which are beyond Calyx's control. Such forward-looking statements or information are based on a number of assumptions, which may prove to be incorrect.

Although Calyx believes that the expectations reflected in such forward-looking statements or information are reasonable, undue reliance should not be placed on forward-looking statements because Calyx can give no assurance that such expectations will prove to be correct. Forward-looking statements or information are based on current expectations, estimates and projections that involve a number of risks and uncertainties which could cause actual results to differ materially from those anticipated by Calyx and described in the forward-looking statements or information.

The forward-looking statements or information contained in this news release are made as of the date hereof and Calyx undertakes no obligation to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise unless so required by applicable securities laws or the TSX Venture Exchange. The forward-looking statements or information contained in this news release are expressly qualified by this cautionary statement.


These press releases may also interest you

at 00:00
SN Bioscience Co. Ltd. (CEO Park Young-hwan) announced on May 7 that the FDA has granted Fast Track Designation for small cell lung cancer (SCLC) for SNB-101 (API: SN-38), a new drug for polymer nanoparticle anticancer under clinical trial. SNB-101...

9 mai 2024
TCI Group is proud to be participating in Phase 1 of the Alliance for Water Stewardship (AWS) Impact Accelerator. Together we are working in Shanghai Jinshan with AWS Members and five other facilities to expand our knowledge, skills and networks to...

9 mai 2024
A research team led by The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has been awarded approximately $11 million over five years by the National...

9 mai 2024
Celltrion USA announced today that adalimumab-aaty, the company's high-concentration (100 mg/mL) and citrate-free formulation biosimilar to HUMIRA ® (adalimumab), is now available at a low wholesale acquisition cost (WAC). Adalimumab-aaty will be...

9 mai 2024
Rakuten Medical, Inc., a global...

9 mai 2024
Healthcare technology company RXNT, a leading developer of ambulatory clinical and practice management software, announced its successful transition to the Relay Exchange clearinghouse via Change Healthcare on May 9th, 2024. This...



News published on and distributed by: